Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Shanthi Rexaline

Merck Continues to See Executive Exodus; Here's A Look At All Recent Departures

Executive churn at pharma giant Merck & Co., Inc. (NYSE:MRK) has increased in recent times, so much so that it has caused stakeholders to sit up and take notice.

What Happened: As recently as Wednesday, New Jersey-based Merck said Roy Baynes, who is serving as head of Global Clinical Development and chief medical officer at Merck Research Labs, will retire from the company in July.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.